Titan Pharmaceuticals, Inc. common stock (TTNP) Stock: Buy, Hold, or Sell?

Titan Pharmaceuticals, Inc. common stock (TTNP) stock has risen 2520.00% over the last 12 months, and the average rating from Wall Street analysts is a Hold. InvestorsObserver’s proprietary ranking system, gives TTNP stock a score of 11 out of a possible 100.

That rank is chiefly influenced by a fundamental score of 0. TTNP's rank also includes a long-term technical score of 13. The short-term technical score for TTNP is 19.

TTNP has an Overall Score of 11. Find out what this means to you and get the rest of the rankings on TTNP!

See Full TTNP Report

What's Happening with TTNP Stock Today

Titan Pharmaceuticals, Inc. common stock (TTNP) stock is down -22.94% while the S&P 500 is unchanged 0% as of 9:47 AM on Tuesday, Dec 1. TTNP is lower by -$1.17 from the previous closing price of $5.10 on volume of 496,220 shares. Over the past year the S&P 500 is up 16.31% while TTNP has risen 2520.00%. TTNP lost -$0.25 per share in the over the last 12 months.

Click Here to get the full Stock Score Report on Titan Pharmaceuticals, Inc. common stock (TTNP) Stock.